MCL-1 is one of the antiapoptotic members of the BCL-2 family, and it has been verified that MCL-1 expression level was significantly upregulated in OSCC tumor tissues and is linked to poor outcome, therapeutic resistance, and disease progression of oral cancers 34-37. This evidence concerns the gene BCL2 and neoplasm.